Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. Radiologic Technologists cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 8, 2014, Pages 1539-1545

  McDonald, Emily ^a,b   Freedman, D Michal ^b   Alexander, Bruce H ^c   Doody, Michele M ^b   Tucker, Margaret A ^b   Linet, Martha S ^b   Cahoon, Elizabeth K ^b  

^a INDIANA UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; PRESCRIPTION DRUG;

ADULT; ADVERSE EFFECTS; BODY MASS; CARCINOMA, BASAL CELL; COHORT ANALYSIS; COMPLICATION; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; OBESITY; RISK FACTOR; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

ADULT; BODY MASS INDEX; CARCINOMA, BASAL CELL; COHORT STUDIES; DIURETICS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PRESCRIPTION DRUGS; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84905505712     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0251     Document Type: Article

References (27)

1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
2. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9.
3. Glatz M, Hofbauer GF. Phototoxic and photoallergic cutaneous drug reactions. Chem Immunol Allergy 2012;97:167-79.
4. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 2002;25:345-72.
5. Stern RS. Photocarcinogenicity of drugs. Toxicol Lett 1998;102-103:389-92.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
7. Alward W L M. Medical management of glaucoma. N Engl J Med 1998;339:1298-307.
8. Sica DA. Diuretic use in renal disease. Nat Rev Nephrol 2012;8:100-9.
9. Sood N, Reinhart KM, Baker WL. Combination therapy for the management of hypertension: a review of the evidence. Am J Health Syst Pharm 2010;67:885-94.
10. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006;48:213-8.
11. Jensen AO, Thomsen HF, Engebjerg MC, Olesen AB, Sorensen HT, Karagas MR. Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer 2008;99:1522-8.
12. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol 2013;133:1950-5.
13. Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M. Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 2010;19:2942-9.
14. Ruiter R, Visser LE, Eijgelsheim M, Rodenburg EM, Hofman A, Coebergh JW, et al. High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer 2010;46:2467-72.
15. Makhzoumi ZH, Arron ST. Photosensitizing agents and the risk of nonmelanoma skin cancer: a population-based case-control study. J Invest Dermatol 2013;133:1922-3.
16. Boice JD Jr, Mandel JS, Doody MM, Yoder RC, McGowan R. A health survey of radiologic technologists. Cancer 1992;69:586-98.
17. Doody MM, Mandel JS, Lubin JH, Boice JD Jr. Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control 1998;9:67-75.
18. Freedman DM, Kimlin MG, Hoffbeck RW, Alexander BH, Linet MS. Multiple indicators of ambient and personal ultraviolet radiation exposure and risk of non-Hodgkin lymphoma (United States). J Photochem Photobiol B 2010;101:321-5.
19. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
20. Cahoon EK, Rajaraman P, Alexander BH, Doody MM, Linet MS, Freedman DM. Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study. Int J Cancer 2012;130:2939-48.
21. Stern RS. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66:553-62.
22. Traianou A, Ulrich M, Apalla Z, De Vries E, Bakirtzi K, Kalabalikis D, et al. Risk factors for actinic keratosis in eight European centres: a casecontrol study. Br J Dermatol 2012;167 Suppl 2:36-42.
23. Kidambi S, Kotchen TA. Treatment of hypertension in obese patients. Am J Cardiovasc Drugs 2013;13:163-75.
24. Modan M, Almog S, Fuchs Z, Chetrit A, Lusky A, Halkin H. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension 1991;17:565-73.
25. Brill MJ, Diepstraten J, Van Rongen A, Van Kralingen S, Van Den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet 2012;51:277-304.
26. Gross TP, Wise RP, Knapp DE. Antihypertensive drug use. Trends in the United States from 1973 to 1985. Hypertension 1989;13:I113-8.
27. Ming ME, Levy RM, Hoffstad OJ, Filip J, Gimotty PA, Margolis DJ. Validity of patient self-reported history of skin cancer. Arch Dermatol 2004;140:730-5.